Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization.
about
Taking Gene Therapy into the ClinicEvolution of animal models in cancer vaccine developmentDirected evolution generates a novel oncolytic virus for the treatment of colon cancerRecent advances in genetic modification of adenovirus vectors for cancer treatmentAn experimental study on cervix cancer with combination of HSV-TK/GCV suicide gene therapy system and 60Co radiotherapy.Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer.Replicative adenoviruses for cancer therapy.Cancer gene therapy: developments to 2000.Head and neck cancer: gene therapy approaches. Part II: genes delivered.Double suicide genes selectively kill human umbilical vein endothelial cells.Double suicide genes driven by kinase domain insert containing receptor promoter selectively kill human lung cancer cellsOncolytic adenoviruses for treatment of brain tumours.Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors.Oncolytic herpes viruses as a potential mechanism for cancer therapy.Oncolytic viral therapies.Replication-selective oncolytic viruses in the treatment of cancer.Gene therapy strategies to improve the effectiveness of cancer radiotherapy.Gene- and immunotherapy for hepatocellular carcinoma.Radiogenic therapy: novel approaches for enhancing tumor radiosensitivity.Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies.Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell LeukemiaA conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapyCombinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model.Oncolytic adenoviruses as antiglioma agents.A double suicide gene system driven by vascular endothelial growth factor promoter selectively kills human hepatocellular carcinoma cells.Armed replicating adenoviruses for cancer virotherapy.Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer.Specifically targeted gene therapy for small-cell lung cancer.Oncolytic viruses: do they have a role in anti-cancer therapy?Oncolytic virotherapy for urological cancers.E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter.Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization.Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector.5-Fluorocytosine increases the toxicity of Wnt-targeting replicating adenoviruses that express cytosine deaminase as a late gene.Heat-directed suicide gene therapy for breast cancer.Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein.Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice.
P2860
Q24792911-2922A221-0B23-45B1-86CD-09F7467B291DQ28080739-B28DE42C-4361-483F-9C5A-0AECEC67F477Q33344440-692324A8-28A0-440B-85A4-15BC333BED3CQ33738828-2DE4E125-B6E0-434C-923A-F56CA60A57C4Q33740015-2D6C067A-CF41-4F3E-BA62-25946358373CQ33838380-FD95E210-F809-4992-B6F4-8B73893B93D7Q33904270-D3137123-0BE2-4F8B-852B-B215DF1BD2AFQ33963944-6FD09B06-972E-474B-9D4E-70F5473DB3B8Q34090963-8CFC67CC-2120-4809-ADF0-10C7EF1CF300Q34560682-E70BFEEB-5114-4550-B2C0-5EFDC8911E1BQ34623656-76913056-3263-4CAD-B1B1-22181CC5BB02Q34748791-A7F3FDBA-23B9-489D-A2E8-060CF59DD973Q35040863-8583CC08-7049-44FA-99C9-DBD6B84C62E8Q35201826-2CA10D80-86E2-4BD9-8828-BF7E9DFEA923Q35613495-7A622487-ECE2-47C4-A390-DFBA6B8A1A03Q35852258-AF6351C4-35E1-46FE-BEFE-04C380EF9C58Q35912403-CF45F252-9AAA-4E07-8748-CE271B0E6F58Q35925611-33F48AAF-28B5-4FD9-A2D0-566D387F5050Q36150432-60F0C018-C7EB-4785-963C-86BBACB1A70FQ36200146-E37C6662-E2D9-497F-BF63-8FB360A07F35Q36258513-508C7350-1595-4279-82A5-DFFDFE299C24Q36281149-08AD055C-C0B6-4A22-8CA9-44A0C223DFE3Q36387946-6A158CC2-907F-478B-888E-BBA2052F35A5Q36422849-674929EB-B192-431C-9AB4-B9017A28BF4AQ36474463-5B802871-E94F-43C0-BD37-D509E846EDE8Q36499227-566575C2-F05A-4D56-B0E6-DA93A488DCCBQ36825943-31877C7B-B705-40EB-A436-A8FDB926B520Q37386616-2F8B0D30-220E-4DB5-9D73-A194031EE4E9Q37448016-02F6C7B9-FCAE-44F7-9112-DB91A0030BE7Q37449030-95386D3C-A23A-4FF8-9207-A94FB866EC8FQ37926486-21E60B27-A2C6-4627-A1B8-522FC4EEA77BQ38842126-9E3B6758-850C-47BB-B4BB-2264E65CAC08Q39935533-17D0B0C0-0A5B-4A99-A34E-049EC1E040CDQ39942987-48F03DBC-73C6-41F2-9676-6E00FB949D95Q40470907-F737FDE3-39A1-4185-AB5E-4764951F9F0BQ40551469-BE2750DE-A356-47C6-A30B-662DEB308BE5Q40601208-8839C971-EE66-4557-955E-5D35C6781B8AQ40657903-52304F02-24C3-48E9-B1A9-D18AFC2F13A4Q40663884-1BCDA6B6-8369-4A26-BC59-D7CC261AD4A7Q40678035-1705DA76-989D-4097-A3DE-0FB32EC88A8F
P2860
Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Double suicide gene therapy au ...... xicity and radiosensitization.
@en
type
label
Double suicide gene therapy au ...... xicity and radiosensitization.
@en
prefLabel
Double suicide gene therapy au ...... xicity and radiosensitization.
@en
P2093
P921
P1433
P1476
Double suicide gene therapy au ...... xicity and radiosensitization.
@en
P2093
P356
10.1089/10430340050016166
P577
2000-01-01T00:00:00Z